Syngene International Share Price Target For Tomorrow, Next Week & Next Month
Syngene International Limited | |||
 | Price: ₹667.60 (+1.28%) | ||
| 52 Week Low: ₹599.55 52 Week High: ₹960.60 | |||
| Market Capital: 27,618.97 Crore (Largecap) | |||
| Healthcare -> Biotechnology | |||
Syngene International Stock Comparison: Syngene International vs Concord Biotech | Syngene International vs Biocon | Syngene International vs Blue Jet Healthcare | Syngene International vs J.B. Chemicals & Pharma | Syngene International vs MEDANTA (Global Health) | Syngene International vs Laurus Labs | |||
Share Price HistorySYNGENE FinancialsTomorrow TargetYearly TargetsDividend HistoryBonus HistoryNo Split
Show Table of Contents
Syngene International Recent Performance
Over the past 436 trading days, the value of Syngene International's stock has lost ₹44.05 (-6.19%). On 07 Nov 2023, one share was worth ₹711.65 and by 14 Aug 2025, the value dropped to ₹667.60. During this period it created a highest high of ₹960.60 and lowest low of ₹599.55.
Syngene International Share Price Target - Tomorrow
| Level | Value | Analysis |
|---|---|---|
| Tomorrow Target 3 | 707.7 (+6%) | Price Action: 07 Apr 2025 High |
| Tomorrow Target 2 | 699.5 (+4.76%) | Price Action: 28 Jul 2025 High |
| Tomorrow Target 1 | 692.05 (+3.66%) | Price Action: 08 Apr 2025 Low |
| Current Price | 667.60 | Syngene International's share price as of 14 Aug 2025 |
| Stop Loss 1 | 645.65 (-3.29%) | Price Action: 14 Jul 2025 High |
| Stop Loss 2 | 638.7 (-4.33%) | Price Action: 23 Jun 2025 High |
| Stop Loss 3 | 632.25 (-5.3%) | Price Action: 22 May 2025 Low |
Summary
14 Aug 2025: Syngene International finished the day at ₹667.60, gaining ₹8.45 (+1.28%) in 1 day.
Our analysis for tomorrow predicts a potential movement of -5.30% to 6.01% with:
- Target prices: ₹692.05 to ₹707.7
- Support levels: ₹645.65 to ₹632.25
- Recent high: ₹672.50
- Recent low: ₹659.55
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Syngene International Share Price Target - Next Week
| Level | Value | Analysis |
|---|---|---|
| Next Week Target 3 | 691.84 (+3.63%) | Fibonacci Extension Level 64.90% |
| Next Week Target 2 | 684.55 (+2.52%) | Price Action: 24 Jul 2025 High |
| Next Week Target 1 | 676.41 (+1.31%) | Fibonacci Extension Level 23.60% |
| Current Price | 667.60 | Syngene International's share price as of 14 Aug 2025 |
| Stop Loss 1 | 664.45 (-0.48%) | Price Action: 23 Jul 2025 Low |
| Stop Loss 2 | 657.3 (-1.55%) | Price Action: May 2025 High |
| Stop Loss 3 | 650 (-2.64%) | Price Action: 24 Apr 2025 Low |
Weekly Target Summary
For next week, our analysis suggests a potential movement range of -2.64% to 3.63% with:
- Upper targets: ₹676.41 to ₹691.84
- Support levels: ₹664.45 to ₹650
Syngene International Share Price Target - Next Month
| Level | Value | Analysis |
|---|---|---|
| Next Month Target 3 | 713.6 (+6.89%) | Price Action: 08 Apr 2025 High |
| Next Month Target 2 | 706 (+5.75%) | Price Action: Jul 2024 Low |
| Next Month Target 1 | 698.7 (+4.65%) | Price Action: 06 Aug 2025 High |
| Current Price | 667.60 | Syngene International's share price as of 14 Aug 2025 |
| Stop Loss 1 | 659.21 (-1.26%) | Technical Indicator: MA50 |
| Stop Loss 2 | 652.45 (-2.27%) | Price Action: 29 May 2025 High |
| Stop Loss 3 | 645.9 (-3.26%) | Price Action: 02 Jul 2025 High |
Monthly Target Summary
Looking ahead to next month, technical analysis indicates:
- Potential price movement: -3.25% to 6.89% with:
- Target range: ₹698.7 to ₹713.6
- Support levels: ₹659.21 to ₹645.9
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
